The 4 most recent market catalysts affecting $DWTX, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Oct 19, 2026
Corporate Catalyst
Bullish
Impact 65
Dogwood Therapeutics Enters Into Securities Subscription Agreement For $5 Investment From CK Life Sciences’ Subsidiary
Dogwood Therapeutics (DWTX) announced a $5 million investment from its largest shareholder, a subsidiary of CK Life Sciences, via a private placement of common stock at $1.22 per s…
Aug 13, 2026
Corporate Catalyst
Bearish
Impact 95
Dogwood Therapeutics Q2 EPS $(0.34) Misses $(0.14) Estimate
Dogwood Therapeutics reported Q2 EPS of $(0.34), missing analyst estimates of $(0.14) by a substantial 142.86%. This significant earnings miss indicates that the company's financia…
Jul 20, 2026
Corporate Catalyst
Bullish
Impact 65
Dogwood Therapeutics Admits First 200 Participants In Its Current HAL-CINP Phase 2b Study To Evaluate Efficacy, Safety Of Halneuron
Dogwood Therapeutics (DWTX) announced a significant operational milestone by successfully enrolling the first 200 patients in its HAL-CINP Phase 2b trial. This indicates progress i…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.